Commentary

DOJ Reaches Deals With NYU Langone and UPMC to End Gender‑Affirming Care for Minors

The settlements stop puberty blockers, cross‑sex hormones and related surgeries for patients under 18 and signal a wider federal push that has narrowed clinical options and intensified legal fights.